Angola Sees Significant Decline in Tuberculosis Deaths and Cases

Angola sees significant decline in tuberculosis deaths and cases, attributed to increased testing, community-based treatment, and coordinated efforts. Despite progress, challenges remain in addressing other health issues like HIV/AIDS and trypanosomiasis.

author-image
Quadri Adejumo
Updated On
New Update
Angola Sees Significant Decline in Tuberculosis Deaths and Cases

Angola Sees Significant Decline in Tuberculosis Deaths and Cases

Angola has witnessed a substantial decrease in tuberculosis deaths and cases in recent years, according to health officials. In 2023, the country reported 503 tuberculosis deaths, marking a reduction of 507 compared to the previous year. This decline is attributed to increased testing by Community Agents - DOT, coordinated actions between various sectors, and an expanded service network by the National Tuberculosis Control Program (PNCT).

The PNCT has significantly increased the number of hospitals capable of diagnosing tuberculosis from 13 (6.3%) in 2018 to 36 (17.3%) in 2022. Additionally, the number of provinces with the capacity to diagnose drug-resistant tuberculosis rose from 14 to 18, and the number of municipalities with care services increased from 111 to 155, achieving a coverage of 95% across the country.

Angola has also seen a decline in malaria deaths , with the number reducing from 12,000 in 2022 to 9,000 in 2023. This progress is attributed to increased access to healthcare, early diagnosis, and timely treatment. The treatment success rate for tuberculosis has also improved due to increased testing, community-based directly observed treatment (DOT), and coordinated actions between various sectors.

Health Minister Sílvia Lutucuta attributed the decline in tuberculosis cases to measures taken to fight endemic diseases, which were reinforced in 2020 with prevention actions against the COVID-19 pandemic. In the last two years, Angola recorded 69,261 tuberculosis cases, 10,739 fewer than the period between 2017 and 2019.

Why this matters: The significant reduction in tuberculosis deaths and cases in Angola demonstrates the effectiveness of targeted public health interventions and coordinated efforts across various sectors. This progress not only improves the health and well-being of Angolan citizens but also serves as a model for other countries facing similar challenges in combating infectious diseases.

Despite the progress made in reducing tuberculosis deaths and cases, Angola still faces challenges in addressing other health issues such as HIV/AIDS and trypanosomiasis (sleeping sickness). The country has over 300,000 citizens living with HIV/AIDS, with 195,000 being women and 35,000 children between 0-14 years old. Health authorities are monitoring 310,000 patients, of which 190,000 are female, with a prevalence rate of 2%. The health units have increased their testing capacity by 116% in 2022 compared to 2017, and the services for preventing mother-to-child transmission of HIV have expanded from 650 in 2017 to 881 in 2022. Regarding trypanosomiasis, the country has seen a reduction from 179 cases in 2012 to 44 cases in 2022, with the goal of eradicating or decreasing the disease by 2030.

Key Takeaways

  • Angola sees substantial decline in TB deaths, from 1,010 in 2022 to 503 in 2023.
  • Increased testing, community-based DOT, and expanded PNCT network contributed to TB decline.
  • Malaria deaths in Angola decreased from 12,000 in 2022 to 9,000 in 2023.
  • Angola has over 300,000 citizens living with HIV/AIDS, with a prevalence rate of 2%.
  • Trypanosomiasis cases reduced from 179 in 2012 to 44 in 2022, aiming for eradication by 2030.